ARC Document Solutions, Inc.

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and immune diseases, announced new data at an investor event in New York City from the ARC-20 platform study, which is evaluating casdatifan, an investigational next-generation HIF-2α inhibitor, alone or in combination, as a first-, second- and late-line treatment for clear c.

HUNTSVILLE, Ala., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Octave Intelligence plc (Nasdaq: OCTV; Nasdaq Stockholm: OCTV SDB), a global leader in software for the world's most mission-critical facilities and infrastructure, today announced that it is the only company named a Leader in both the ARC Advisory Group's MarketMap for Enterprise Asset Management and the MarketMap for Digital Worker Technologies for Manufacturing . ARC also classified Octave as a Transformation Pioneer in Enterprise Asset Management (EAM).

New York, NY, Sept. 23, 2026 (GLOBE NEWSWIRE) -- ARC Group Securities Acquisition I (the “Company” (Nasdaq:  FJDIU ) (the “Company”) today announced that, commencing on or about September 24, 2026, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares, warrants and rights included in the units.

~ Transaction values Firstborn Top Capital at pro forma enterprise value of approximately $1,091.2 million ~~ Firstborn Top Capital is a licensed private financing company committed to providing responsible, transparent and accessible financial solutions to individuals and businesses across Malaysia ~~ Executive Director, Ow Ruey Shen, will continue to lead Firstborn Top Capital ~~ Transaction provides Firstborn Top Capital the capital to accelerate growth throughout Malaysia, then Southeast Asia ~~ Business combination expected to close in the first quarter of 2027 ~~ All Firstborn Top Capital shareholders to sell 100% of their equity to ARC Group Acquisition I Corp ~

Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd.

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)

Expands Nanox's growing U.S. distribution network with a leading New England-based medical imaging provider PETACH TIKVA, Israel — September 4 2026 — Nano-X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its U.S.-based subsidiary, Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp., a New England-based provider of medical imaging equipment and services, specializing in X-ray, MRI, and CT systems, to support deployment of the Nanox.ARC across the region.

EINDHOVEN, the Netherlands, Sept. 03, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces the first implant in the EIGER clinical feasibility study evaluating the investigational ARC-IM® System for restoring mobility in people with subacute or chronic spinal cord injury (SCI).